Prevalence of BRCA1 and BRCA2 mutations in male breast cancer patients in Canada

Clin Breast Cancer. 2000 Apr;1(1):57-63; discussion 64-5. doi: 10.3816/CBC.2000.n.005.

Abstract

Men who inherit a mutation in the BRCA2 gene carry a 6% risk of developing breast cancer by the age of 70. The proportion of male breast cancers attributable to BRCA mutations has not yet been determined with accuracy. We studied a series of 14 male breast cancer patients, unselected for family history or ethnicity, who were treated at a single regional cancer center in Canada. Family histories were obtained, and the men were tested for germ-line mutations of BRCA1 and BRCA2. Seven of these patients had a significant family history of breast cancer (i.e., at least one first- or second-degree relative with breast cancer diagnosed before age 70). Two of the men carried BRCA2 mutations, but no BRCA1 mutations were found. Both mutation carriers reported a positive family history and a personal history of cancer that preceded their diagnosis of breast cancer. Our results support the recommendation that male breast cancer patients who have a significant family history of breast or ovarian cancer should be offered genetic counseling and testing.

MeSH terms

  • Adult
  • Age Distribution
  • Age of Onset
  • Aged
  • Alcoholism / complications
  • Breast Neoplasms, Male / diagnosis
  • Breast Neoplasms, Male / epidemiology
  • Breast Neoplasms, Male / genetics*
  • DNA Mutational Analysis / methods
  • Genes, BRCA1*
  • Genes, BRCA2*
  • Genetic Counseling
  • Genetic Predisposition to Disease / epidemiology
  • Genetic Predisposition to Disease / genetics
  • Genetic Testing / methods
  • Germ-Line Mutation / genetics*
  • Heterozygote
  • Humans
  • Male
  • Medical History Taking
  • Middle Aged
  • Ontario / epidemiology
  • Pedigree
  • Prevalence
  • Registries
  • Risk Factors